Musk’s Neuralink says cleared for human test of brain implants

Published by

San Francisco (AFP) – Elon Musk’s start-up Neuralink on Thursday said it has approval from US regulators to test its brain implants in people. Neuralink said clearance from the US Food and Drug Administration (FDA) for its first in-human clinical study is “an important first step” for its technology, which is intended to let brains interface directly with computers. “We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study,” Neuralink said in a post on Musk-run Twitter. Recruitment for a clinical trial is not yet open, according to Neuralink….

Read More

See also  Compass UOL And Furious Technologies Announce Partnership To Provide Data-driven Pricing Solutions

Leave a Reply